Clean Sweep Live Auction on Wed. May 1st. Click to view the full inventory

DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Pediatrics
Current Location:
> This Story

Forward Printable StoryPrint Comment




Cardiology Homepage

Leading vascular surgeon presents comparative data analysis on EndoAVF procedures at Society of Interventional Radiology 2019

Intact Vascular’s Tack Endovascular System receives FDA approval

iSchemaView’s RAPID approved for use in the Kingdom of Saudi Arabia

Stryker launches LIFEPAK CR2 defibrillator with LIFELINKcentral AED program manager in the United States

Avinger (AVGR) announces receipt of FDA 510(k) clearance of Pantheris SV device

BIOTRONIK launches PK Papyrus covered coronary stent in the US

Insera earns CE Mark approval for cyclical-suction stroke thrombectomy platform, the CLEAR aspiration system

iSchemaView’s RAPID approved for use in Israel

Seisa Medical announces acquisition of Burpee MedSystems

Study finds lower death rates for TAVR centers that do more procedures

Integrating heart disease and cancer care could reduce overall healthcare costs, according to researchers

Press releases may be edited for formatting or style
PLYMOUTH MEETING, Pa., Feb. 20, 2019 /PRNewswire/ -- New research in the February 2019 issue of JNCCN—Journal of the National Comprehensive Cancer Network calls for much greater integration between cardiologists and oncologists for patients with coronary artery disease (CAD) who are diagnosed with cancer. CAD—commonly referred to as clogged arteries—is the most-common type of heart of disease, and the leading cause of death in the United States. The researchers found that CAD-related medical expenses were considerably higher for patients with this chronic condition who were also diagnosed with cancer, particularly colorectal cancer.

"Heart problems that needed to be treated with in-patient hospitalization accounted for the highest added expenditures; representing two-thirds of the total costs," explained lead researcher Ishveen Chopra, PhD, MBA, Department of Pharmaceutical Systems and Policy, West Virginia University. "There is a need for more coordinated and patient-centered care among older adults with multiple chronic conditions. An interdisciplinary and integrated approach to cardiovascular management in the elderly diagnosed with incident cancer would improve cardiovascular outcomes."

Story Continues Below Advertisement

Servicing GE Nuclear Medicine equipment with OEM trained engineers

We offer full service contracts, PM contracts, rapid response, time and material,camera relocation. Nuclear medicine equipment service provider since 1975. Click or call now for more information 800 96 NUMED

The study used the SEER-Medicare registry as well as a 5% non-cancer random sample of Medicare beneficiaries to compare costs for 12,095 CAD patients diagnosed with breast, colorectal, or prostate cancer, against the costs of 34,237 CAD patients with no cancer. All were continuously enrolled in traditional, fee-for-service Medicare plans. Every individual was 68-years-old or older, and remained alive during the entire 48-month study period. Health care expenses were measured every 120 days during the one-year pre- and one-year post-cancer diagnosis, and were adjusted by the Consumer Price Index for medical services and expressed in 2012 dollars.

The results showed that CAD expenses post-cancer diagnosis increased approximately three times over pre-cancer costs, for people with colorectal cancer. The post-cancer diagnosis expenses were twice as high for women with breast cancer, and one-and-a-half times higher for men with prostate cancer. At the same time, CAD costs in the noncancer group remained steady for the entire time period.

The authors speculated that some of the cost increases could stem directly from cancer treatment.

"Treatment regimens used for colorectal cancer may increase cardiotoxicity and therefore increase the CAD management cost to patients," said Dr. Chopra. "In addition, non-adherence to CAD medications during cancer treatment may also contribute to higher CAD complications and total overall costs."
  Pages: 1 - 2 - 3 >>

Cardiology Homepage

You Must Be Logged In To Post A Comment

Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Gold Service Dealer Program
Receive RFP/PS
Healthcare Providers
See all
HCP Tools
A Job
Parts Hunter +EasyPay
Get Parts
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2019 DOTmed.com, Inc.